SWE ORPHAN BIOVITRU (B6E BE) stock market data APIs
€25.5381
0(0%)
as of September 17, 2025
Try our APIs with
free plan!
SWE ORPHAN BIOVITRU Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for B6E.BE.
Prev. Close
25.5381
Open
25.5381
High
25.5381
Low
25.5381
52 wk Range
23.02-30.56
Market Cap
5 414 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SWE ORPHAN BIOVITRU data using free add-ons & libraries
Get SWE ORPHAN BIOVITRU Fundamental Data
SWE ORPHAN BIOVITRU Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SWE ORPHAN BIOVITRU News
New
Is Sobi Set for a Rebound After Shares Drop 16% in 2024?
If you are holding shares of Swedish Orphan Biovitrum or considering whether now is the moment to buy in, you are probably weighing its recent performance against its long-term potential. The stock pr...
Invitation: Sobi's NASP and Uncontrolled Gout call and webcast
NASP (previously known as SEL-212) - clinical program overview and uncontrolled gout disease landscape. STOCKHOLM, Sept. 10, 2025 /PRNewswire/ -- Investors, analysts, and members of the media are inv...
FDA Accepts Biologics License Application for Sobi's NASP for Patients with Uncontrolled Gout
Submission includes results of the pivotal DISSOLVE I and II studies NASP PDUFA date set for 27 June 2026 STOCKHOLM, Sept. 10, 2025 /PRNewswire/ -- Sobi® (STO: SOBI), a global biopharmaceutical comp...
New number of shares and votes in Sobi
STOCKHOLM, Aug. 29, 2025 /PRNewswire/ -- As per 29 August 2025, the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi®) amounts to 357,412,837 shares, of which 356,000,049 are common...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
